SATisfaction and adherence to COPD treatment

Study identification

• EU PAS number:
  EUPAS13605
• Study ID:
  13606
• Official title and acronym:
  SATisfaction and adherence to COPD treatment
• DARWIN EU® study:
  No
• Study countries:
  Italy
• Study description:
  The present study will explore the patients’ satisfaction to COPD medical treatment (i.e. pharmacological and not pharmacological treatment) in a clinical real-world setting and how the satisfaction for medical treatment is related to clinical parameters, quality of life, illness perception and treatment adherence evolution. Moreover health care resource consumption will be observed during the observation period.
• Study status:
  Finalised

Research institutions and networks

Institutions

Boehringer Ingelheim

Study timelines

Date when funding contract was signed

Planned:08/09/2015

Actual:08/09/2015

Study start date

Planned:25/11/2015

Actual:25/11/2015

Date of final study report

Planned:31/12/2017

Actual:30/08/2018

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Boehringer-Ingelheim

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable